ProstaLund AB announced that the product Schelin Catheter has been registered and approved for sale in Switzerland. At the same time, the company has signed a couple of distribution agreements with some distributors. The first orders will be delivered during the current quarter.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.57 SEK | +3.64% | 0.00% | -65.03% |
05-31 | ProstaLund Secures Order for CoreTherm System in Austria | MT |
05-16 | ProstaLund AB Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
1st Jan change | Capi. | |
---|---|---|
-65.03% | 4M | |
-2.07% | 187B | |
+0.52% | 110B | |
-1.87% | 69.54B | |
+13.99% | 46.37B | |
-6.86% | 46.05B | |
+7.97% | 42.54B | |
+18.42% | 30.72B | |
+17.70% | 25.62B | |
-7.48% | 23.32B |
- Stock Market
- Equities
- PLUN Stock
- News ProstaLund AB
- ProstaLund AB Announces Registration and Approval of Product Schelin Catheter for Sale in Switzerland